<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="1626">
<titleInfo>
<title>Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2020 , Vol 24 Issue 2</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text"></placeTerm></place>
<publisher></publisher>
<dateIssued></dateIssued>
<issuance>monographic</issuance>
<edition>Vol 24 Issue 2</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Karya Tulis Ilmiah</form>
<extent></extent>
</physicalDescription>
<note>ABSTRACT: The oral hypoglycaemic agents as well as injectable insulin does not significantly alter the oxidative
stress in the diabetes mellitus patients. Being an antioxidant Vitamin C (ascorbic acid) might help in tackling the
adversities of reactive oxygen species. A randomized placebo controlled study was carried out with parallel
assignment of both the test group and control group of patients. The intervention model included metformin 500mg
twice daily and a placebo once daily for control group. Alternatively, Vitamin C chewable tablets were given for the
other group along with metformin 500mg twice daily. Our study postulates that there is a significant reduction in
the fasting blood glucose, glycosylated haemoglobin levels, troponin T levels and Framingham risk score in
participants who received ascorbic acid supplementation along with regular metformin. The supplementation of
Vitamin C along with Metformin was well tolerated and did not cause any serious adverse drug reactions. The
cheaper cost adjuvant approach with Vitamin C may be beneficial in patients in reducing the cardiovascular risk as
well as to maintain an appropriate glycaemic control
KEYWORDS: Diabetes Mellitus; ascorbic acid; glycemic control; cardiovascular risk.</note>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0090</numerationAndChronology>
<sublocation>Perpus.Akfarsam (jurnal Internasioan)</sublocation>
<shelfLocator>615 MAR b</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="1701" url="https://drive.google.com/file/d/1A0cQCaH-GB5z_1lEYWJDQEUiGSqSHaL-/view?usp=sharing" path="/https://drive.google.com/file/d/1A0cQCaH-GB5z_1lEYWJDQEUiGSqSHaL-/view?usp=sharing" mimetype="text/uri-list">Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2020 , Vol 24 Issue 2</slims:digital_item>
</slims:digitals><recordInfo>
<recordIdentifier>1626</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2022-07-20 11:52:39</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2022-07-20 11:54:29</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>